Bearberry (Uva Ursi): Evidence & Safety Context

Identify the actual ingredient

The label names Arctostaphylos uva-ursi leaf. It does not disclose a separate bearberry weight or a preparation matching a named clinical study. Knowing the plant and plant part is a starting point; it does not complete the comparison.

Product names sometimes use bearberry and uva ursi interchangeably. When reviewing a paper or monograph, compare the botanical identity, plant part, extraction method, and amount rather than stopping at the common name.

What the EMA assessment means

EMA’s public summary discusses traditional use of specific bearberry leaf preparations for mild recurrent lower-urinary-tract symptoms after serious conditions are excluded. It limits those preparations to short-term use and includes kidney-related restrictions. The assessment is not an approval of FEMICORE or its combination.

That distinction prevents two errors: calling traditional use a finished-product trial, and taking instructions for one preparation as instructions for another. This site does not convert a monograph into a dosing schedule for the capsule.

Why package duration needs scrutiny

A seller may offer enough bottles for several months. The offer is a commercial quantity, not proof that every ingredient is appropriate for that duration. Before buying a large supply, ask a clinician or pharmacist to consider the complete formula, your conditions, and your medicines.

What a responsible conclusion looks like

The supplied label establishes that bearberry is declared in the blend. The cited assessment supplies context for a different, specified herbal-use framework. Neither tells us the rate of FEMICORE side effects or proves a benefit for bladder leaks.

Read the safety guide before making a purchase decision. New urinary symptoms should be assessed rather than interpreted as an automatic reason to take a traditional urinary herb.

Continue your research